Data as of:
Price 02-03-26 16:00 ET,
Balance Sheet 2025-09-30,
Income Statement 2025-09-30,
Cash Flow 2025-09-30
Indicators
Dividend indicators
Value
Date
Pays Dividend
No
2-1-2026
Income indicators
Value
Date
EBITDA Positive
No
2-1-2026
Net Income Positive
No
2-1-2026
Avg CA Burn (Annual %)
-8.28%
2-1-2026
Avg CA Burn (Quarterly %)
1.66%
2-1-2026
Shares Outstanding Changes
Date
Shares Outstanding
Delta
2025-11-10
57,189,381
+29,578
2025-09-17
57,159,803
+3
2025-08-12
57,159,800
+36,700
Short Interest Changes
Latest short interest:
8,139,354 shares
(21.39% of float)
| Days to cover: 8.34
Date
Short Interest
Delta
Δ %
2026-02-03
8,139,354 shares
+0
+0.00%
2026-02-02
8,139,354 shares
+0
+0.00%
2026-01-30
8,139,354 shares
None
—
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
Date
Volume
Shares Outstanding
Volume / Shares
Price
No interesting volume events
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.